Evidence map›Paper›PMID 32027876›Full record

ArticleThe Journal of investigative dermatology2020

Flotillin and AP2A1/2 Promote IGF-1 Receptor Association with Clathrin and Internalization in Primary Human Keratinocytes.

Duncan Hieu M Dam, Sophia A Jelsma, Jeong Min Yu, Haoming Liu, Betty Kong, Amy S Paller

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of investigative dermatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Adapter protein 2-modulatedActa pharmacologica Sinica · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. The roles of FLOT1 in human diseases (Review).Molecular medicine reports · 2023
    Review
  7. Article
  8. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Duncan Hieu M DamDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Sophia A JelsmaDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Jeong Min YuDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Haoming LiuDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Betty KongDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Amy S PallerDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Electronic address: apaller@northwestern.edu.
Northwestern University · US

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Daniela E Matei · 1993 to 2026
$153.9M
Northwestern University Skin Disease Research Center Resource-based CenterP30AR075049 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Amy S Paller · 2019 to 2026
$6.6M
The Role of Keratinocytes as Independent ThermosensorsP30AR057216 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI PALLER, AMY S · 2009 to 2018
$6.0M
Neuron-Keratinocyte Communication in the Epidermis in Normal and Diabetic Wound HealingR01AR077691 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MENICHELLA, DANIELA M, PALLER, AMY S · 2020 to 2023
$2.6M
Post Graduate Program in Cutaneous BiologyT32AR060710 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Amy S Paller · 2012 to 2026
$2.4M
Glycosphingolipids Mediate Diabetic Wound Healing ImpairmentR01AR068375 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI PALLER, AMY S · 2016 to 2020
$2.1M
NCI NIH HHS P30 CA060553NIAMS NIH HHS P30 AR057216NIAMS NIH HHS P30 AR075049NIAMS NIH HHS R01 AR068375NIAMS NIH HHS R01 AR077691NIAMS NIH HHS T32 AR060710
6 · The paper itself

Abstract

IGF-1 receptor (IGF1R) signaling promotes keratinocyte proliferation, migration, and survival. However, the mechanism of IGF1R endocytosis in normal keratinocytes remains unclear. Confocal, super resolution structured illumination microscopy, total internal reflection fluorescence microscopy, and coimmunoprecipitation studies reveal that IGF1R associates with flotillin-1 (Flot-1), which currently has no known role in normal receptor tyrosine kinase endocytosis, under basal conditions in monolayer keratinocyte cultures. Ligand stimulation of IGF1R promotes its clathrin-dependent endocytosis, mediated by two distinct adaptors, Flot-1 in noncaveolar lipid rafts and the AP2A1/2 complex in clathrin vesicles. Concurrent, but not individual, short hairpin RNA knockdown of FLOT1/2 and AP2A1/2 reduced IGF1R association with clathrin, internalization, and pathway activation by more than 50% (of phosphorylated IGF1R, phosphorylated protein kinase B, and phosphorylated MAPK kinase), suggesting the complementarity of these two adaptor-specific pathways. The Flot-1 pathway is more responsive to low IGF-1 concentrations, whereas the AP2A1/2 pathway predominates at higher IGF-1 concentrations. Selective association of IGF1R-Flot-1-clathrin with Rab4, but IGF1R-AP2A1/2-clathrin with Rab11, implicates Flot-1 as the adaptor for faster recycling and AP2A1/2 as the adaptor for slower IGF1R recycling. These dual pathways, particularly flotillin-dependent, clathrin-mediated endocytosis, provide a new avenue for drug targeting in disorders with aberrant regulation of IGF1R signaling.

Indexed as

Adaptor Protein Complex 2Adaptor Protein Complex alpha SubunitsCells, CulturedClathrinEndocytosisGene Knockdown TechniquesHumansIntravital MicroscopyKeratinocytesMembrane ProteinsMicroscopy, FluorescencePrimary Cell CultureReceptor, IGF Type 1Adaptor Protein Complex 2adaptor protein complex 2, alpha 2 subunitAdaptor Protein Complex alpha SubunitsAP2A1 protein, humanClathrinflotillinsIGF1R protein, humanMembrane ProteinsReceptor, IGF Type 1

Identifiers

PMID32027876
PMCPMC7396279
OpenAlexW3004241105

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.